Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1939 1
1946 3
1947 2
1948 1
1950 1
1951 2
1952 3
1953 1
1955 3
1957 1
1959 1
1960 3
1963 2
1964 1
1965 6
1966 1
1967 2
1969 2
1971 2
1972 1
1974 2
1975 2
1976 3
1977 3
1978 2
1979 4
1980 2
1981 3
1982 7
1983 7
1984 5
1985 10
1986 11
1987 5
1988 9
1989 14
1990 3
1991 4
1992 5
1993 3
1994 1
1995 3
1996 3
1997 8
1998 9
1999 8
2000 3
2001 2
2002 11
2003 10
2004 9
2005 6
2006 4
2007 3
2008 2
2009 6
2010 2
2011 2
2012 2
2014 2
2015 3
2016 4
2017 4
2018 3
2019 4
2020 2
2021 3
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

258 results
Results by year
Filters applied: . Clear all
Page 1
Highly Selective Inhibition of Tyrosine Kinase 2 (TYK2) for the Treatment of Autoimmune Diseases: Discovery of the Allosteric Inhibitor BMS-986165.
Wrobleski ST, Moslin R, Lin S, Zhang Y, Spergel S, Kempson J, Tokarski JS, Strnad J, Zupa-Fernandez A, Cheng L, Shuster D, Gillooly K, Yang X, Heimrich E, McIntyre KW, Chaudhry C, Khan J, Ruzanov M, Tredup J, Mulligan D, Xie D, Sun H, Huang C, D'Arienzo C, Aranibar N, Chiney M, Chimalakonda A, Pitts WJ, Lombardo L, Carter PH, Burke JR, Weinstein DS. Wrobleski ST, et al. Among authors: pitts wj. J Med Chem. 2019 Oct 24;62(20):8973-8995. doi: 10.1021/acs.jmedchem.9b00444. Epub 2019 Jul 18. J Med Chem. 2019. PMID: 31318208
Systemic atropine and glaucoma.
Greenstein SH, Abramson DH, Pitts WR 3rd. Greenstein SH, et al. Among authors: pitts wr 3rd. Bull N Y Acad Med. 1984 Dec;60(10):961-8. Bull N Y Acad Med. 1984. PMID: 6394092 Free PMC article. Review. No abstract available.
Osteitis condensans ilii.
Soucy JC Jr, Pitts WH Jr, Soucy JC Sr, Smyth CJ. Soucy JC Jr, et al. Among authors: pitts wh jr. JAMA. 1969 Feb 10;207(6):1145-7. JAMA. 1969. PMID: 5818340 No abstract available.
Discovery of highly potent, selective, covalent inhibitors of JAK3.
Kempson J, Ovalle D, Guo J, Wrobleski ST, Lin S, Spergel SH, Duan JJ, Jiang B, Lu Z, Das J, Yang BV, Hynes J Jr, Wu H, Tokarski J, Sack JS, Khan J, Schieven G, Blatt Y, Chaudhry C, Salter-Cid LM, Fura A, Barrish JC, Carter PH, Pitts WJ. Kempson J, et al. Among authors: pitts wj. Bioorg Med Chem Lett. 2017 Oct 15;27(20):4622-4625. doi: 10.1016/j.bmcl.2017.09.023. Epub 2017 Sep 11. Bioorg Med Chem Lett. 2017. PMID: 28927786
Identification of RIPK3 Type II Inhibitors Using High-Throughput Mechanistic Studies in Hit Triage.
Hart AC, Abell L, Guo J, Mertzman ME, Padmanabha R, Macor JE, Chaudhry C, Lu H, O'Malley K, Shaw PJ, Weigelt C, Pokross M, Kish K, Kim KS, Cornelius L, Douglas AE, Calambur D, Zhang P, Carpenter B, Pitts WJ. Hart AC, et al. Among authors: pitts wj. ACS Med Chem Lett. 2019 May 6;11(3):266-271. doi: 10.1021/acsmedchemlett.9b00065. eCollection 2020 Mar 12. ACS Med Chem Lett. 2019. PMID: 32184955 Free PMC article.
258 results